首頁 > 市場調查報告書 > 製藥

感染疾病

抗菌藥物抗藥性監測市場規模、佔有率及成長分析（按組件、技術、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1914058

抗菌藥物抗藥性監測市場規模、佔有率及成長分析（按組件、技術、最終用戶和地區分類）－2026-2033年產業預測

Antimicrobial Resistance Surveillance Market Size, Share, and Growth Analysis, By Component (Software, Hardware), By Technology (Phenotypic Methods, Genotypic Methods), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月30日 | 出版商:

SkyQuest | 英文 191 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球抗生素抗藥性監測市場規模預計在 2024 年達到 62.3 億美元，從 2025 年的 65.8 億美元成長到 2033 年的 101.7 億美元，在預測期（2026-2033 年）內複合年成長率為 5.6%。

抗菌素抗藥性日益普遍的構成日益嚴重的全球健康威脅，促使各國政府、衛生組織和政府間聯盟加強監測系統。抗藥性感染疾病的增加推動了對即時數據收集、病原體追蹤和抗藥性模式分析的需求，凸顯了先進抗菌素抗藥性監測解決方案的必要性。公共衛生應對能力的提升和對感染控制的日益重視正在顯著推動市場擴張。同時，監管標準和國際計劃也在推動監測能力的增強。許多國家正在投資檢查室基礎設施、整合數據平台和即時數據報告工具，以加強這些監測系統。醫療服務提供者正在利用這些進步來實施感染控制通訊協定，從而促進抗菌藥物管理並減少醫療相關感染，為市場的持續成長奠定基礎。

全球抗菌素抗藥性監測市場促進因素

抗藥性感染疾病的日益普遍已成為全球重大的公共衛生問題。抗藥性的快速上升促使各國政府和衛生組織開發先進的監測系統，以便即時檢測抗藥性模式並迅速做出反應。國家和地方政府已認知到加強抗生素抗藥性監測的迫切性，並為此共同努力，以防止感染傳播、最大限度地減少治療失敗，並協助制定國家衛生政策。這種日益增強的意識和對有效監測解決方案的需求是推動全球抗生素抗藥性監測市場成長的關鍵因素。

限制全球抗菌素抗藥性監測市場的因素

建立有效的抗菌素抗藥性監測系統面臨許多挑戰，其中之一是實驗室基礎設施、數據整合技術以及專業人員培訓所需的大量資金投入。在資源往往有限的低收入國家，這項挑戰尤其突出。此外，利用基因組學方法分析監測數據成本高昂，進一步限制了全球抗菌素抗藥性監測舉措的推廣和實施。這些資金和營運方面的障礙阻礙了進展，限制了市場的潛在成長，凸顯了進行有針對性的投資和國際合作以加強全球監測能力的必要性。

全球抗菌素抗藥性監測市場趨勢

全球抗菌藥物抗藥性監測市場正經歷一個顯著趨勢：人工智慧 (AI) 與基因組調查方法的融合。先進的人工智慧平台與全基因測序和生物資訊學的融合正在革新抗藥性基因的檢測方式，從而能夠更準確、更快速地識別抗菌藥物威脅。這種技術協同作用不僅增強了醫療系統在疫情爆發期間發布即時警報的能力，而且顯著提升了預測建模能力，最終促成更有效的干涉策略。這顯著提高了全球醫療系統的監測能力，並促進了針對抗菌藥物抗藥性的主動應對措施。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

bioMerieux SA（France）
Thermo Fisher Scientific Inc.（USA）
BD（USA）
Roche Diagnostics（Switzerland）
OpGen Inc.（USA）
Luminex Corporation（USA）
Accelerate Diagnostics Inc.（USA）
Merck KGaA（Germany）
Danaher Corporation（USA）
Bruker Corporation（USA）
QuantuMDx Group Ltd.（United Kingdom）
ArcBio LLC（USA）
Bugworks Research Inc.（India）

結論與建議

簡介目錄

Product Code: SQMIG35G2347

Global Antimicrobial Resistance Surveillance Market size was valued at USD 6.23 Billion in 2024 and is poised to grow from USD 6.58 Billion in 2025 to USD 10.17 Billion by 2033, growing at a CAGR of 5.6% during the forecast period (2026-2033).

The escalating prevalence of antimicrobial resistance poses significant global health threats, prompting a coalition of governments, health organizations, and intergovernmental bodies to enhance surveillance systems. There is an increasing demand for real-time data collection, pathogen tracking, and resistance pattern analysis as drug-resistant infections rise, highlighting the necessity for sophisticated antimicrobial resistance surveillance solutions. This heightened emphasis on public health readiness and infection management is substantially propelling market expansion. In tandem, regulatory standards and international initiatives are driving the enhancement of surveillance capabilities. Many nations are investing in laboratory infrastructure, integrated data platforms, and immediate data reporting tools to strengthen these surveillances. Healthcare providers are leveraging these advancements to align with infection control protocols, thereby promoting antimicrobial stewardship and reducing healthcare-related infections, paving the way for sustained market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Antimicrobial Resistance Surveillance market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Antimicrobial Resistance Surveillance Market Segments Analysis

Global Antimicrobial Resistance Surveillance Market is segmented by Component, Technology, End User and region. Based on Component, the market is segmented into Software, Hardware and Services. Based on Technology, the market is segmented into Phenotypic Methods, Genotypic Methods and Bioinformatics Solutions. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes and Public Health Agencies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Antimicrobial Resistance Surveillance Market

The escalating prevalence of drug-resistant infections has emerged as a serious global public health concern. The surge in resistance rates has prompted federal and health organizations to develop sophisticated surveillance systems capable of detecting resistance patterns in real-time, facilitating prompt response measures. As both national and local governments recognize the critical need for enhanced antimicrobial resistance surveillance, there is a concerted effort to avert outbreaks, minimize treatment failures, and support the formation of national health policies. This heightened awareness and demand for effective monitoring solutions are key factors driving the growth of the global antimicrobial resistance surveillance market.

Restraints in the Global Antimicrobial Resistance Surveillance Market

The development of an effective antimicrobial resistance surveillance system is hindered by substantial financial requirements for laboratory infrastructure, data integration technologies, and the training of skilled personnel. This challenge is particularly pronounced in lower-income nations, where resources are often limited. Moreover, the expensive nature of analyzing surveillance data through genomic methods further restricts the reach and implementation of global antimicrobial resistance surveillance initiatives. These financial and operational barriers collectively impede progress and limit the potential growth of the market, highlighting the need for targeted investments and international collaboration to enhance surveillance capabilities worldwide.

Market Trends of the Global Antimicrobial Resistance Surveillance Market

The Global Antimicrobial Resistance Surveillance market is experiencing a notable trend of integrating artificial intelligence (AI) with genomic surveillance methodologies. This convergence of advanced AI platforms with whole-genome sequencing and bioinformatics is revolutionizing the detection of resistance genes, thus facilitating more precise and timely identification of antimicrobial threats. This technological synergy not only enhances the ability of healthcare systems to provide real-time alerts during outbreaks but also significantly strengthens predictive modeling, ultimately leading to more effective intervention strategies. As a result, the surveillance capabilities of healthcare systems globally are being substantially improved, fostering proactive measures against antimicrobial resistance.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies

Global Antimicrobial Resistance Surveillance Market Size by Component & CAGR (2026-2033)

Market Overview
Software
Hardware
Services

Global Antimicrobial Resistance Surveillance Market Size by Technology & CAGR (2026-2033)

Market Overview
Phenotypic Methods
Genotypic Methods
Bioinformatics Solutions

Global Antimicrobial Resistance Surveillance Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals and Clinics
Diagnostic Laboratories
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Public Health Agencies

Global Antimicrobial Resistance Surveillance Market Size & CAGR (2026-2033)

North America (Component, Technology, End User)
- US
- Canada
Europe (Component, Technology, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Component, Technology, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Component, Technology, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Component, Technology, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OpGen Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accelerate Diagnostics Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuantuMDx Group Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ArcBio LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bugworks Research Inc. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments